explore -WSS

explore

author：comprehensive 2025-10-04 11:35:55 - browse：11687

Person wearing a smart watch. -- first opinion coverage from STAT — Adobe

The Apple Watch has secured a new qualification from the Food and Drug Administration that could make the smartwatch an appealing tool for medical device companies hoping to illustrate the benefits of a common heart procedure.

Last week, the Apple Watch’s Atrial Fibrillation History feature became the first digital tool qualified under the Medical Device Development Tools (MDDT) program. Released in 2022, the feature estimates a user’s A-fib burden, or how much time they spend in atrial fibrillation, which is an irregular heart rhythm that can cause shortness of breath and fatigue, and is also linked to an increased risk of stroke.

The qualification means that FDA has determined in advance that sponsors can use the feature as a secondary endpoint in clinical trials without having to do additional work. Specifically, the Apple Watch is qualified for use as a secondary endpoint in clinical trials for cardiac ablation devices, which reduce the electrical signals that cause A-fib by scarring the heart with extreme heat or cold energy. Pulsed field ablation is the latest version of the technology, using a controlled electric field to scar tissue rather than the riskier thermal energy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

focus

WSS

Stroke rates rising, especially in working

Organ aging and disease risk measured by new blood test

Hospitals need to get ahead of regulations on climate change

Bird flu makes raw milk dangerous to consume, mouse study finds

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

U.K. Biobank has 500,000 peoples' genome sequences available

entertainment

explore

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

leisure time

State Dept. review finds Biden bears some blame for Afghanistan failures

Protect nursing home residents from future pandemics

Supreme Court strikes down use of affirmative action

Should insurance cover cosmetic surgery?

Sports medicine is finally prioritizing gender equality

What don’t we know about an Alzheimer’s drug side effect?

DIEP, the 'gold standard' of breast reconstruction, is under threat

Achieving telehealth equity for people with hearing loss

New air purifier tech could be key to improving indoor air quality

Why we need mandatory labeling of GMO products

knowledge

How to pay for weight loss drugs and save Medicare

FDA investigates CAR

J&J to emphasize cancer drugs, stop much of its vaccine research

CDC director unscathed in first congressional testimony

How to pay for weight loss drugs and save Medicare

Disappointing trial forces Pfizer to pivot on obesity medicine plans

focus

focus

knowledge

focus